Additionally, TGP treatment significantly increased the proportion and number of Tregs among lupus CD4+ T cells, indicating that TGP may inhibit autoimmunity in SLE patients by promoting Treg differentiation (Zhao et al., 2012). Here, CD4 is linked to systemic lupus erythematosus.